Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

Similar articles for PubMed (Select 23389039)

1.

Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia.

Tao YF, Pang L, Du XJ, Sun LC, Hu SY, Lu J, Cao L, Zhao WL, Feng X, Wang J, Wu D, Wang N, Ni J, Pan J.

Int J Mol Sci. 2013 Feb 6;14(2):3376-94. doi: 10.3390/ijms14023376.

2.

Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays.

Yan-Fang T, Dong W, Li P, Wen-Li Z, Jun L, Na W, Jian W, Xing F, Yan-Hong L, Jian N, Jian P.

Cancer Cell Int. 2012 Sep 8;12(1):40. doi: 10.1186/1475-2867-12-40.

3.

Analyzing the gene expression profile of anaplastic histology Wilms' tumor with real-time polymerase chain reaction arrays.

Lu J, Tao YF, Li ZH, Cao L, Hu SY, Wang NN, Du XJ, Sun LC, Zhao WL, Xiao PF, Fang F, Xu LX, Li YH, Li G, Zhao H, Ni J, Wang J, Feng X, Pan J.

Cancer Cell Int. 2015 Apr 20;15:44. doi: 10.1186/s12935-015-0197-x. eCollection 2015.

4.

Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.

Patani N, Jiang WG, Newbold RF, Mokbel K.

Anticancer Res. 2011 Dec;31(12):4115-25.

PMID:
22199269
5.

16-hydroxycleroda-3,13-dien-15,16-olide regulates the expression of histone-modifying enzymes PRC2 complex and induces apoptosis in CML K562 cells.

Lin YH, Lee CC, Chang FR, Chang WH, Wu YC, Chang JG.

Life Sci. 2011 Dec 5;89(23-24):886-95. doi: 10.1016/j.lfs.2011.09.011. Epub 2011 Sep 29.

PMID:
21983300
6.

High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.

Deguchi Y, Yamanaka Y, Theodossiou C, Najfeld V, Kehrl JH.

Leukemia. 1993 Mar;7(3):446-51.

PMID:
7680402
7.

Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata.

Zhao M, Liang G, Wu X, Wang S, Zhang P, Su Y, Yin H, Tan Y, Zhang J, Lu Q.

Br J Dermatol. 2012 Feb;166(2):226-73. doi: 10.1111/j.1365-2133.2011.10646.x. Epub 2012 Jan 9.

PMID:
21936853
8.

Transforming pathways unleashed by a HDAC2 mutation in human cancer.

Ropero S, Ballestar E, Alaminos M, Arango D, Schwartz S Jr, Esteller M.

Oncogene. 2008 Jun 26;27(28):4008-12. doi: 10.1038/onc.2008.31. Epub 2008 Feb 11.

PMID:
18264134
9.

Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.

Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N, Maruyama T, Seki N, Nishino N, Yoshida M, Matsubara H.

Int J Oncol. 2012 Sep;41(3):985-94. doi: 10.3892/ijo.2012.1537. Epub 2012 Jun 28.

PMID:
22752059
10.

Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.

Scupoli MT, Donadelli M, Cioffi F, Rossi M, Perbellini O, Malpeli G, Corbioli S, Vinante F, Krampera M, Palmieri M, Scarpa A, Ariola C, FoĆ  R, Pizzolo G.

Haematologica. 2008 Apr;93(4):524-32. doi: 10.3324/haematol.12098. Epub 2008 Mar 5.

11.

Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.

Canale S, Cocco C, Frasson C, Seganfreddo E, Di Carlo E, Ognio E, Sorrentino C, Ribatti D, Zorzoli A, Basso G, Dufour C, Airoldi I.

Leukemia. 2011 Dec;25(12):1815-24. doi: 10.1038/leu.2011.158. Epub 2011 Jun 24.

PMID:
21701492
12.

Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.

Tesfai Y, Ford J, Carter KW, Firth MJ, O'Leary RA, Gottardo NG, Cole C, Kees UR.

Leuk Res. 2012 Mar;36(3):299-306. doi: 10.1016/j.leukres.2011.08.001. Epub 2011 Sep 1.

PMID:
21889797
14.

Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Bhatia S, Kaul D, Varma N.

Mol Cell Biochem. 2011 Jan;346(1-2):103-16. doi: 10.1007/s11010-010-0597-0. Epub 2010 Oct 6.

PMID:
20924650
16.

Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Ge Y, Haska CL, LaFiura K, Devidas M, Linda SB, Liu M, Thomas R, Taub JW, Matherly LH.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):451-7.

17.

Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.

Paggetti J, Largeot A, Aucagne R, Jacquel A, Lagrange B, Yang XJ, Solary E, Bastie JN, Delva L.

Oncogene. 2010 Sep 9;29(36):5019-31. doi: 10.1038/onc.2010.254. Epub 2010 Jun 28.

PMID:
20581860
18.

Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia.

Moreno DA, Scrideli CA, Cortez MA, de Paula Queiroz R, Valera ET, da Silva Silveira V, Yunes JA, Brandalise SR, Tone LG.

Br J Haematol. 2010 Sep;150(6):665-73. doi: 10.1111/j.1365-2141.2010.08301.x.

PMID:
20636436
19.

HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.

Starkova J, Zamostna B, Mejstrikova E, Krejci R, Drabkin HA, Trka J.

Pediatr Blood Cancer. 2010 Dec 1;55(6):1072-82. doi: 10.1002/pbc.22749.

PMID:
20672366
20.

Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.

Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Tima S, Chanarat P, Limtrakul P.

Arch Pharm Res. 2006 Oct;29(10):866-73.

PMID:
17121181
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk